Aimei Health Technology Co Ltd

For the period ended Mar 31, 2024. Filed May 13, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 13, 2024

AFJK$12.20-0.1%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Balance Sheets

	March 31, 2024	December 31, 2023
ASSETS
Cash	$413,747	$580,717
Prepaid expenses	66,667	-
Due from a related company	302	-
Total current assets	480,716	580,717
Cash and marketable securities held in Trust Account	70,798,980	69,889,848
TOTAL ASSETS	$71,279,696	$70,470,565
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accrued expenses	$78,472	$24,841
Total current liabilities	78,472	24,841
Deferred underwriting compensation	690,000	690,000
TOTAL LIABILITIES	768,472	714,841
Commitments and contingencies	-	-
Ordinary shares, subject to possible redemption. 6,900,000 and 6,900,000 shares issued and outstanding at redemption value of $10.26 and $10.13 as of March 31, 2024 and December 31, 2023, respectively	70,798,980	69,889,848
Stockholders’ deficit:
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,126,000 and 2,126,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively (excluding 6,900,000 and 6,900,000 shares subject to possible redemption, respectively)	213	213
Accumulated deficit	(287,969)	(134,337)
Total Stockholders’ Deficit	(287,756)	(134,124)
TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ DEFICIT	$71,279,696	$70,470,565

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.